Posts Tagged ‘mouse models’

Dr William Bengston cures Cancer in Mice with Energy Healing.

Sunday, March 25th, 2018

Dr William F. Bengston is a professor of statistics and research methods, and the President of the Society for Scientific Exploration, an international group of scientists and researchers who study anomalies.  Dr. Bengston has been researching anomalous healing for over thirty five years, and has numerous publications in scientific journals.  He has also lectured widely in the U.S., Canada, and Europe.

His memoir, The Energy Cure, is published by Sounds True.  Bill’s research has produced the first successful full cures of transplanted mammary cancer and methylcholanthrene induced sarcomas in mice by energy healing techniques that he helped to develop.  He has also investigated assorted correlates to healing such as EEG and fMRI entrainment, and geomagnetic micropulsation anomalies in healing space.  His current research focuses on the attempt to record and store healing in both biological and physical systems, and to be able to reproduce the healing effect without the healer.

Enjoy the Interview below:



Can Bitter Melon Prevent Pancreatic Cancer?

Wednesday, March 20th, 2013

logo1267406_mdA recent study published in the journal Carcinogenesis concluded that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus, cutting the energy supply to the cells and eventually killing them. This study goes beyond an earlier study in a petri dish that showed the effects of bitter melon on breast cancer cells. while exploring the effect of bitter melon on pancreatic cancer cells the research says they found an “Alterations in metabolic events in pancreatic cancer cells and an activation of the AMP=activated protein kinase, an enzyme that indicates low energy levels in the cells.” In a later study using a mouse model they found that when mice were fed bitter melon juice they were 60% less likely to develop pancreatic cancer than the controls. Researchers said “Many researchers are engineering new drugs to target cancer cells’ ability to supply themselves with energy, and here we have a naturally-occurring compound that may do just that.” Further trials are planned.